Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM180A | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | LRRCC1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | RP13-512J5.1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | ABI1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | THAP12 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | AMELX | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
mRNA | PNISR | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | TMEM9B | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | PPP1R11 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | SGMS2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |